2 of 5 unlisted pharmas struggling with SG&A/sales ratio higher than 40%
2 of 5 unlisted pharmaceutical companies reportedly have the ratio of SG&A(selling, general and administrative) expenses to sales higher than 40%.
Yakup Shinmoon(www.yakup.com) analyzed 2017 audit reports that 82 unlisted pharmaceutical companies submitted to the Financial Supervisory Service, a...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
